Analysis, BioTech, Life Science and Patient Experience

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. It enables the delivery of traditional, hybrid and decentralised clinical trials while enhancing the patient experience.

Life Science

Life Science Digital Health Drug Development Patient Experience

Bonus Features – November 20, 2022 – 90% of healthcare buyers prioritize virtual care but want a clear roadmap, wearable data helped predict COVID-19 infections 12 days before the CDC, and more

Healthcare IT Today

NOVEMBER 20, 2022

Patient-owned research platform Savvy Cooperative has partnered with ProofPilot , maker of an automated digital protocol platform for clinical trials. Insurer K&B Underwriters has teamed up with VirtuSense Technologies to offer fall risk analysis and prevention tools to post-acute care organizations.

eCare

eCare BioTech Primary Care Life Science

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

MARCH 6, 2019

In this Vantage analysis , Jonathan Gardner observed that Lilly’s action on generic insulin “took a leaf out of Mylan’s book” in their response to public outcry on EpiPen pricing. . “Humalog isn’t thirteen times as effective as it used to be.

Pharmaceuticals

Pharmaceuticals Life Science Medicare BioTech

Connected Health Pulse

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Bonus Features – November 20, 2022 – 90% of healthcare buyers prioritize virtual care but want a clear roadmap, wearable data helped predict COVID-19 infections 12 days before the CDC, and more

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Stay Connected